Life Stem Genetics
Life Stem Genetics Inc., a development stage company, focuses on establishing stem cell therapy based clinics worldwide. Its products and services include nutraceutical and medical supplements, and IV nutritional cocktails; stem cell banking services; stem cell treatments for degenerative conditions, hyperbaric oxygen therapy, cancer treatments, and weight loss; anti-aging stem cell therapy; anti… Read more
Life Stem Genetics (LIFS) - Total Assets
Latest total assets as of April 2014: $566.90K USD
Based on the latest financial reports, Life Stem Genetics (LIFS) holds total assets worth $566.90K USD as of April 2014.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Life Stem Genetics - Total Assets Trend (2012–2013)
This chart illustrates how Life Stem Genetics’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Life Stem Genetics - Asset Composition Analysis
Current Asset Composition (July 2013)
Life Stem Genetics's total assets of $566.90K consist of 27.1% current assets and 72.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 27.1% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $283.00 | 72.9% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2012–2013)
This chart illustrates how Life Stem Genetics's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Life Stem Genetics's current assets represent 27.1% of total assets in 2013, a decrease from 100.0% in 2012.
- Cash Position: Cash and equivalents constituted 27.1% of total assets in 2013, down from 100.0% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2012.
- Asset Diversification: The largest asset category is property, plant & equipment at 72.9% of total assets.
Life Stem Genetics Competitors by Total Assets
Key competitors of Life Stem Genetics based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
464680
KQ:464680
|
Korea | ₩31.23 Billion |
|
Cartesian Growth Corporation III Unit
NASDAQ:CGCTU
|
USA | $281.56 Million |
|
Azure Holding Group Corp
PINK:AZRH
|
USA | $16.92 Million |
|
Constellation Capital Corp.
V:CNST-P
|
Canada | CA$627.53K |
|
Little Fish Acquisition I Corp.
V:LILL-P
|
Canada | CA$56.48K |
|
Hana 30 Special Purpose Acquisition Company
KQ:469880
|
Korea | ₩17.89 Billion |
|
Chicane Capital I Corp.
V:CCIC-P
|
Canada | CA$199.07K |
|
Cuspis Capital II Ltd
V:CCII-P
|
Canada | CA$1.51 Million |
Life Stem Genetics - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Life Stem Genetics generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Life Stem Genetics is currently not profitable relative to its asset base.
Life Stem Genetics - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.22 | 0.43 | 0.03 |
| Quick Ratio | 1.22 | 0.43 | 0.03 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $48.01K | $ -5.53K | $ -9.25K |
Life Stem Genetics - Advanced Valuation Insights
This section examines the relationship between Life Stem Genetics's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.13 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -95.0% |
| Total Assets | $388.00 |
| Market Capitalization | $0.91 USD |
Valuation Analysis
Below Book Valuation: The market values Life Stem Genetics's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Life Stem Genetics's assets decreased by 95.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Life Stem Genetics (2012–2013)
The table below shows the annual total assets of Life Stem Genetics from 2012 to 2013.
| Year | Total Assets | Change |
|---|---|---|
| 2013-07-31 | $388.00 | -95.01% |
| 2012-07-31 | $7.78K | -- |